T1	Action 18 26	compared
T2	Concept 34 52	DMSO control group
T3	Concept 59 65	CVL218
T4	Concept 70 80	remdesivir
T5	Action 81 87	showed
T6	Concept 88 94	potent
A1	Emphasized T6
T7	Concept 95 115	antiviral activities
T8	Concept 127 136	full-time
T9	Concept 137 146	procedure
T10	Concept 154 174	SARS-CoV-2 infection
T11	Concept 178 185	Vero E6
T12	Concept 186 191	cells
R1	target Arg1:T1 Arg2:T2	
R2	subject Arg1:T1 Arg2:T3	
R3	subject Arg1:T1 Arg2:T4	
R4	subject Arg1:T5 Arg2:T4	
R5	subject Arg1:T5 Arg2:T3	
R6	target Arg1:T5 Arg2:T7	
R7	has-property Arg1:T7 Arg2:T6	
R8	has-part Arg1:T9 Arg2:T8	
R9	in-time Arg1:T7 Arg2:T9	
R10	in-context Arg1:T9 Arg2:T10	
R11	in-context Arg1:T7 Arg2:T11	
R12	is-a Arg1:T11 Arg2:T12	
T13	Concept 198 202	S416
T14	Concept 219 233	best efficient
T15	Concept 234 242	chemical
T16	Concept 243 249	so far
T17	Concept 250 257	against
T18	Concept 258 268	SARS-CoV-2
T19	Concept 276 290	cellular level
R13	has-property Arg1:T13 Arg2:T14	
R14	is-a Arg1:T13 Arg2:T15	
R15	in-time Arg1:T14 Arg2:T16	
R16	in-context Arg1:T14 Arg2:T17	
R17	has-part Arg1:T17 Arg2:T18	
R18	in-place Arg1:T14 Arg2:T19	
T20	Concept 306 310	SARS
T21	Concept 311 316	virus
T22	Concept 291 298	Similar
T23	Concept 318 332	viral genomics
T24	Concept 337 355	structural biology
T25	Concept 356 363	studies
R19	has-part Arg1:T23 Arg2:T25	
R20	has-part Arg1:T24 Arg2:T25	
T26	Action 364 374	have shown
T27	Concept 380 384	ACE2
T29	Concept 395 414	functional receptor
T28	Concept 423 426	new
T30	Concept 427 437	SARS-CoV-2
T31	Concept 438 449	coronavirus
R21	subject Arg1:T26 Arg2:T25	
R22	is-a Arg1:T27 Arg2:T29	
R23	target Arg1:T26 Arg2:T27	
R24	in-context Arg1:T29 Arg2:T30	
R25	has-property Arg1:T30 Arg2:T28	
R26	is-a Arg1:T30 Arg2:T31	
T32	Concept 452 458	recent
T33	Concept 459 464	study
T34	Action 465 473	revealed
T35	Concept 479 489	SARS-CoV-2
T36	Action 495 499	uses
T37	Concept 504 524	cell entry receptor,
T38	Concept 525 554	angiotensin converting enzyme
T39	Concept 558 562	ACE2
T40	Concept 570 577	similar
T41	Concept 581 589	SARS-CoV
R27	subject Arg1:T34 Arg2:T33	
R28	has-property Arg1:T33 Arg2:T32	
R29	target Arg1:T34 Arg2:T35	
R30	subject Arg1:T36 Arg2:T35	
R31	target Arg1:T36 Arg2:T37	
R32	in-context Arg1:T37 Arg2:T38	
*	same-as T38 T39
R33	in-context Arg1:T36 Arg2:T40	
R34	in-context Arg1:T40 Arg2:T41	
T42	Concept 590 619	Hospital-related transmission
T43	Concept 635 655	causes for infection
T44	Concept 659 678	health-care workers
R35	is-a Arg1:T42 Arg2:T43	
R36	in-context Arg1:T43 Arg2:T44	
T45	Concept 699 711	early stages
A2	Emphasized T45
R37	in-time Arg1:T42 Arg2:T45	
T46	Concept 715 732	COVID-19 epidemic
R38	in-context Arg1:T45 Arg2:T46	
T47	Concept 681 691	especially
R39	has-property Arg1:T45 Arg2:T47	
T48	Concept 750 767	lack of knowledge
R40	in-context Arg1:T43 Arg2:T48	
T49	Concept 768 797	about transmission approaches
R41	in-context Arg1:T48 Arg2:T49	
T50	Concept 801 811	SARS-CoV-2
R42	in-context Arg1:T49 Arg2:T50	
T51	Concept 852 884	shortage of protective materials
T52	Concept 831 837	period
T53	Action 843 849	facing
R43	target Arg1:T53 Arg2:T51	
R44	has-property Arg1:T53 Arg2:T52	
R45	in-context Arg1:T43 Arg2:T53	
